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Abstract
Background: There is increasing evidence for hormone-dependent modification of function and behavior during the
menstrual cycle, but little is known about associated short-term structural alterations of the brain. Preliminary studies
suggest that a hormone-dependent decline in brain volume occurs in postmenopausal, or women receiving antiestrogens,
long term. Advances in serial MR-volumetry have allowed for the accurate detection of small volume changes of the brain.
Recently, activity-induced short-term structural plasticity of the brain was demonstrated, challenging the view that the brain
is as rigid as formerly believed.
Methodology/Principal Findings: We used MR-volumetry to investigate short-term brain volume changes across the
menstrual cycle in women or a parallel 4 week period in men, respectively. We found a significant grey matter volume peak
and CSF loss at the time of ovulation in females. This volume peak did not correlate with estradiol or progesterone hormone
levels. Men did not show any significant brain volume alterations.
Conclusions/Significance: These data give evidence of short-term hormone-dependent structural brain changes during the
menstrual cycle, which need to be correlated with functional states and have to be considered in structure-associated
functional brain research.
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Introduction
There is a vast amount of evidence for hormone-dependent
modification of function and behavior during the menstrual cycle, but
little is known about associated structural alterations of the brain
[1,2,3,4,5]. Modern MR-techniques not only are capable to elucidate
inter-individual brain atrophy during senescence or degenerative
processes,but recently have also allowed for the discernment of short-
term structural alterations induced by training [6]. This is evidence
that the structure of the adult brain is not as rigid as formerly believed
and can be visualized in humans. The expanding possibilities with
respect to in vivo investigation into brain str u c t u r em a k ei tm a n d a t o r y
for us to increase our understanding of the physiological parameters
affecting brain morphology. Both the function as well as the structure
of the human brain are strongly dependent on sex and may be
influenced by genetic as well as hormonal factors [2,7,8,9,10]. The
hormonal influence on brain function and behavior is caused by
developmental organizational effects and later on through modifica-
tion and activation-related effects during maturation and adulthood
[4,7,8,11,12,13]. Furthermore, there are preliminary data demon-
strating a long-term decline in brain volume in postmenopausal
women or in women receiving antiestrogens, which can be prevented
by hormone replacement therapy [14,15,16]. This finding suggests
that estrogens may exert a measurable neuroprotective effect on the
brain. Experimental work on rodents demonstrated that there are
estrous dependent synaptic rearrangements in several brain regions
which are functional significant and probably could be the underlying
mechanism of gross morphological brain changes [5,17].
Here we investigated, non-invasively, short-term brain volume
changes during the menstrual cycle in women or a parallel 4 week
period in men, respectively.
Methods
Subjects
Sixteen healthy volunteers (8 females and 8 eight males) were
included in the study. The study protocol was approved by the
local ethics committee (Ethik-Kommission der Friedrich-Schiller-
Universita ¨t Jena), and all subjects gave written informed consent.
Confounding comorbidity was excluded by an interview, with
special emphasis on endocrine dysfunction and hypertension. No
subjects were on medication, including hormonal contraceptives.
All volunteers were asked to refrain from alcohol consumption the
night before and coffee intake the morning before scanning. Each
scanning session was scheduled early in the morning at the same
time (7:30 am), with minimal food and fluid intake. Each male was
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or four time points during the respective menstrual cycle.
Scanning took place during menses (t1), at time of ovulation (t2),
and in the midluteal phase (t3). Half of the subjects were scanned
again at the beginning of the next menses (t4). Only women known
to have an ovulational cyclus were allowed for the scanning
protocol. This was achieved by an intravaginal ultrasound
performed by an experienced gynecologist. To ascertain an
ovulational cyclus and the time point of ovulation (t2) during the
month the actual MR-scanning took place, ultrasound was
repeated and scanning at t2 took place the day after a follicle
ready for ovulation was detected. Furthermore, in women, blood
samples were taken at each scanning session and serum levels of
estradiol and progesterone were evaluated, while excluding other
hormonal alterations (thyroid function, testosterone, cortisol).
MRI
Image data were acquired on a 1.5 T Siemens Vision using a
standard birdcage head coil with a T1-weighted fl3d Gradient
Echo Sequence (GRE, TR=15 ms, TE=5 ms, a=30u, 192
slices, sagittal orientation, voxel size 16161m m
3). To increase
the signal-to-noise ratio and to minimize the effects of different
head positioning, subjects were scanned twice at each recording
session with the subject exiting the scanner between scans. We
used a longitudinal design with several repeated measures as this is
much more powerful than a simple cross-sectional design with only
one measure per subject [18,19]. Data were visually checked for
artifacts and any structural pathology.
Data analysis
Data pre-processing and analysis was performed using SPM2
(Wellcome Department of Cognitive Neurology, London, UK).
First, all scans of each subject were registered to the first baseline
scan to correct the position of each scan without changing brain
size. The first scan of each subject was then used to align this
image to the default SPM2-template. The estimated alignment
parameters of this process were finally applied to all other scans of
each subject, to assure that the overall correction in brain size was
the same for each subject, while the position was corrected
individually. All images were partitioned into grey and white
matter (GM/WM), cerebrospinal fluid (CSF) and background
using a modified mixture model cluster analysis, after correcting
for non-uniformities in image intensity [20]. In order to remove
unconnected non-cerebral voxels, we applied a series of morpho-
logical erosions and dilations to the segmented images. To
calculate tissue volume, we summed up the values for each
compartment over the whole brain. Statistical analysis was
performed by testing the interaction between sex and time for
the time points t2-t4. We used an AnCova model with baseline
values (t1) as nuisance parameter to control for the different brain
size between females and males. The AnCova model was chosen
because of the higher statistical power compared to the use of
percentage change from baseline [21]. In females, we additionally
tested the hypothesis that the relative volume changes were
correlated with hormone levels. As the estradiol peak is a marker
for the time of ovulation, correlations were calculated for volume-
differences at time point t2 versus t1. Progesterone dominates the
second half of the menstrual cycle, therefore, correlations were
calculated for volume-differences at time point t3 versus t1.
Results
All but one female showed hormone level modulation during
the menstrual cycle which was typical for an ovulational cycle
(fig. 1). The time point of ovulation was estimated by ultrasound
(t2). One subject showed no increase in progesterone at t3,
indicating missing ovulation, and was excluded, along with the
matched male. So, data from seven females (age range: 21–31 y)
and seven males (age range: 23–37 y) were included in the analysis
of volumetric data. In females, GM showed a significant volume
increase at ovulation (t2 versus t1) (+1.81 %, p,0.05) and a
corresponding volume loss in CSF (24.4 %; p,0.05) (fig. 2). All
WM volume changes and relative volume changes between other
time points did not show any significant alterations. In males there
was no significant difference in the relative volume changes of
WM, GM and CSF during the 4 week period. For a ‘‘standard’’
brain of 1350 ml, the volume changes described in our study
allowed for the calculation of a total brain volume increase at
ovulation of , 13,5 ml.
Although the relative volume changes of GM and CSF between
time points t1 and t3 were not significant, these volume changes
showed a significant correlation with progesterone changes (fig. 3;
GM: r=20.72; p,0.05; CSF: r=0.84; p,0.001). There was no
statistical correlation between the significant volume changes
between t2 and t1, and estradiol changes, which were clearly
highest at time of ovulation (t2, see fig. 1).
Discussion
We demonstrate for the first time that brain morphology varies
during the menstrual cycle, with a (grey matter) volume peak at
time of ovulation which can be estimated to be ,13,5 ml for a
‘‘standard’’ brain.
It is tempting to speculate that there is a causal relationship
between hormone levels and brain volumes. During the menstrual
cycle estradiol levels show a marked peak at ovulation and
progesterone levels rise afterwards with a broader peak towards
the next menses. However, we could not detect a significant
correlation between the grey matter volume peak and the estradiol
peak when taken all female subjects into account. On the other
hand the brain volume change, and even more so the associated
loss in CSF-volume between t1 and t3 which by itself was not
significant, correlates well with changes in progesterone levels. In a
similar study on pregnant women, Oatridge et al. describe a ,5%
brain volume loss during pregnancy with a minimal volume at
term and a normalization during the few months postpartum [22].
As both estradiol and progesterone levels increase during
pregnancy, no conclusions can be drawn as to which hormone
contributes to this volume change in the cited study.
We found the lack of correlation between the estradiol rise and
the volume changes in our study between t1 and t2 puzzling and,
therefore, reanalyzed the data after excluding one statistical outlier
(.2SD difference from the mean): Having done this, there was a
significant correlation between GM and CSF volumes between
time points t1 and t2 and estradiol changes (GM: r=0.79;
p,0.05; CSF: r=20.76; p,0.05, data not shown) with
persistence of a significant grey matter volume peak at time of
ovulation. We are well aware that this further reduces our sample
size and can only be done with caution. On the other hand this
may be a first hint encouraging further, larger studies, to explore
this interrelation in more detail.
In the long-term, there are preliminary data suggesting a
neuroprotective role for estrogens on age-related temporal atrophy
[14]. This effect is most pronounced in postmenopausal women
and can be accentuated with hormone replacement therapy
[15,16]. Other steroid hormones like cortisol are also known to
decrease brain size long-term [23]. Recently, Cho (2001)
demonstrated that even ‘‘physiologically’’ elevated stress induced
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temporal lobe atrophy associated with decreased memory
performance after 5 years of service [24]. Little, however, is
known about short-term steroid effects on brain volume. As
expected, cortisol levels were stable across the menstrual cycle
in our group (data not shown), excluding any confounding ef-
fects. Up to now, it is not clear which microscopical mechanisms
underlie brain volume changes: contributions can be attributed
to changes in vascular supply, intra- or intercellular water
shifts, cell hypertrophy, synaptogenesis or even (neuro-)neogenesis
[6,22,25,26,27].
There is compelling experimental evidence that brain structural
alteration do occur in adulthood. The formation and turn-over of
new neocortical synapsiscan be induced inan experience-dependent
manner and is probably even increased after injury, hereby
facilitating reorganization and recovery of function after injury
[27,28,29] Hatton and colleagues demonstrated increased den-
dritic bundling of supraoptic neurons after the induction of
maternal behavior [30]. Adult neurogenesis has been identified
in all vertebrate species examined thus far [31]. It can be increased
or modified by e.g. by exercise, enriched environment, epileptic
seizures or during pregnancy [26,32,33,34]. Up to now it is
not clear, which functional role newborn neurons play. They
may have a beneficial contribution to adaptational processes as
well as represent a meaningless side effect [34,35,36]. It is, how-
ever, only a remote possibility that the amount of new neurons
can significantly contribute to macroscopical alterations of brain
morphology.
Figure 1. Quantitative hormone changes during the menstrual cycle for estradiol and progesterone of all 8 female subjects. For
clarification, time points are connected by straight lines. Note: only half of the subjects were measured at t4; part of the lines overlie. All but one
subjects showed hormone levels within physiological levels and indicating ovulatory cycles: This is an increase of estradiol levels at t2 and/or elevated
progesterone levels after t2. One subject showed no increase in progesterone at t3, indicating missing ovulation, and was excluded from further
studies, along with the matched male.
doi:10.1371/journal.pone.0014655.g001
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synaptogenesis and synaptic rearrangements, which have been
described in rodents, also play a role in humans: in rats fast
estrous-dependent or estrogen induced changes of spine density
have been described in several brain regions including CA1
neurons in the hippocampus and the ventromedial nucleus of the
hypothalamus [2,5,17,37,38,39,40]. At least in the hippocampus
there is evidence that estrogen not only increases the number of
spines per se but also the number of spines with multiple
presynaptic boutons ending on different postsynaptic cells [5].
Such network alterations with new connections may have
important functional implications, both, in terms of pathophysi-
ology of disease as well as for long-term potentiation (LTP) which
is assumed to be a model of learning and memory. They may alter
the excitability of the hippocampus, potentially underlying the
decrease in seizure threshold seen with estrogen treatment and
across the estrous cycle, as well as the estrogen-dependent
increment and facilitation of LTP [39,41,42]. Although these are
rodent studies, they might suggest that synaptogenesis is an
underlying mechanism of the grey matter changes observed.
On a functional as well as structural level in humans a vast
amount of studies suggest that neuroactive steroids play a role in
sexual dimorphism (for rev. [9,10]. There are clear-cut sexual
differences in specific cognitive tasks, in behavior and in the
vulnerability to depression and anxiety [11,43,44]. Furthermore,
memory and learning, pain perception, and susceptibility to
seizures are among the CNS functions which are modulated by
steroids [45,46,47,48]. Some but not all of these effects show
menstrual cycle dependent fluctuations. The diversity of functional
CNS-effects, which steroids exert on the brain suggests that they
modify widespread brain regions. Besides the classical genomic
mechanism by which steroids bind to intracellular receptors [49],
it is now clear that they can also act via direct membrane
mechanisms, such as ligand-gated ion channels and neurotrans-
mitter transporters, which do not depend on estrogen receptors
[50,51,52]. This may be an explanation for the widespread actions
of estrogens on the brain. In addition, recent work describes
estrogen receptors not only on neuronal cells but also on astrocytes
and oligodendrocytes [52,53]. At present, less is known about
estrogen and progesterone receptors in the human brain
Figure 3. Correlation between the (not significant) relative volume change of grey matter and CSF in females between t3 and t1
and progesterone levels at the appropriate time points.
doi:10.1371/journal.pone.0014655.g003
Figure 2. Relative volume change of grey and white matter and CSF between 4 time points during the menstrual cycle in women
and in men, respectively. In females (right columns), there is a significant increase in grey matter at the time of ovulation and a corresponding loss
of CSF compared to men (p,0.05, asterix). t1: Menses, t2: ovulation; t3 midluteal phase; t4: next menses. The data are displayed as boxplot, where 50
% of data are in the box and whiskers depict range of data. Note: different scale of y-axes.
doi:10.1371/journal.pone.0014655.g002
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brain steroid receptors are abundant. However, the wide
abundance of steroid effects on the brain gives no further
explanation why we found significant volume differences only in
grey matter.
Functional imaging studies suggest cycle-dependent changes of
activation patterns which are most pronounced for cognitive tasks
[1,56,57,58,59]. They are task and region specific and do not
necessarily go along with observational effects [1,58]. There is
uncertainty as to whether hormone levels correlate with cycle-
dependent lateralization of specific tasks and spatial extent and/or
activation pattern [1,8,56,57,58]. Changes in the spatial extent of
activation can probably be explained by direct vascular effects of
estrogen, which is a known vasodilator and could hereby influence
brain volume as measured with MRI [60]. The estrogen peak
shortly before ovulation could also underlie the brain volume peak,
but could not be demonstrated in our subjects before removing
one statistical outlier (s. above).
There are several pitfalls of MR-volumetry which have to be
considered: physiological parameters like water balance and
nutrition may interact with brain volume to a degree which is in
the range to be expected with degenerative disease and of the same
magnitude we found in our study [25,61]. However, we minimized
these factors by measuring at fixed time points early in the
morning with restricted fluid and food intake.
The paucity of conclusive neuroimaging data of hormone effects
on brain activity in humans can partly be explained by poor
control of hormone levels in most of these studies. On the other
hand, might it be a misconception that all sex differences can and
have to be explained solely by sex hormones [8]. Our structural
observation of cycle-dependent brain volume changes highlights
the need to control for phase of the menstrual cycle and hormone
levels not only when investigating into function but also in
quantitative structure-associated brain imaging, especially in
longitudinal studies. It might even be wise to concentrate on
either males or females. Although, up to now we can only
speculate on what is responsible for the brain volume changes
during the menstrual cycle, the changes are too pronounced to
ignore them in the future. Furthermore, our results give further
evidence of the short-term plasticity of the human brain and it
remains to be investigated whether they reflect the structural
correlates of cycle-dependent functional states.
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